Westphal, Sabine <br/><br/>
Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction.  [electronic resource] 

 -  Coronary artery disease  Jan 2009 
 - 81-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1473-5830 
<br/><br/><label>Standard No.: </label>10.1097/MCA.0b013e32831a8811  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Brachial Artery--drug effects<br/>Capsules<br/>Chemistry, Pharmaceutical<br/>Cross-Over Studies<br/>Delayed-Action Preparations<br/>Dietary Fats--administration & dosage<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Endothelium, Vascular--diagnostic imaging<br/>Fatty Acids, Monounsaturated--administration & dosage<br/>Female<br/>Fluvastatin<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Hyperlipidemias--blood<br/>Indoles--administration & dosage<br/>Male<br/>Metabolic Syndrome--diagnostic imaging<br/>Middle Aged<br/>Postprandial Period<br/>Regional Blood Flow<br/>Tablets<br/>Time Factors<br/>Treatment Outcome<br/>Triglycerides--blood<br/>Ultrasonography<br/>Vasodilation--drug effects